welcome to the sikora lab
welcome to the sikora lab
Embedded Files
The Sikora Lab was launched in August 2016. With our research group focusing on invasive lobular carcinoma of the breast, we strive to create an environment where our staff and early-career researchers (ECRs; students, postdocs, and fellows) can advance both our collective research efforts and their own unique training and career development goals.
OUR MISSION
OUR MISSION
AT THE BENCH
Understand steroid hormone signaling in cancer, with a focus on response to endocrine therapy and anti-estrogen resistance in breast cancer.
Understand steroid hormone signaling mechanisms in invasive lobular carcinoma of the breast.
TOWARD THE CLINIC
Improve the outcomes of patients with hormone-dependent breast cancer and other cancers primarily affecting women.
FOR OUR RESEARCH COMMUNITY
Train productive, collaborative, and responsible members of the scientific community.
RECENT ANNOUNCEMENTS
RECENT ANNOUNCEMENTS
Accepting Students
We are recruiting graduate students from these CU Anschutz PhD programs:
Biomedical Sciences Program | Cancer Biology | Pharmacology | Molecular Biology
Still in college? Contact us for undergraduate research opportunities or check out a list of programs here.
Publications
Read the Sikora Lab's recent work on an unexpected sensitivity to FDA-approved "PARP inhibitors" in ILC.
Our review on radiotherapy for the treatment of ILC was featured in Breast Cancers Today.
News
Watch videos from our outreach and education events to learn about the unique biology and clinical management of lobular breast cancer, our lab's research on ILC, and our partnership with the advocacy group Front Range ILC.
Learn more about the collaborative peer group co-founded by Dr. Sikora, focused on the research and career development of scientists studying nuclear receptors.
Page updated
Google Sites
Report abuse